Chemicals - Specialty
Compare Stocks
5 / 10Stock Comparison
KOP vs TROX vs IOSP vs AVNT vs BCPC
Revenue, margins, valuation, and 5-year total return — side by side.
Chemicals
Chemicals - Specialty
Chemicals - Specialty
Chemicals - Specialty
KOP vs TROX vs IOSP vs AVNT vs BCPC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Chemicals - Specialty | Chemicals | Chemicals - Specialty | Chemicals - Specialty | Chemicals - Specialty |
| Market Cap | $807M | $1.34B | $1.91B | $3.35B | $5.11B |
| Revenue (TTM) | $1.88B | $2.92B | $1.78B | $3.28B | $1.06B |
| Net Income (TTM) | $56M | $-359M | $117M | $158M | $158M |
| Gross Margin | 17.9% | 5.8% | 27.7% | 31.7% | 36.3% |
| Operating Margin | 8.9% | -4.8% | 8.7% | 9.3% | 21.0% |
| Forward P/E | 9.8x | — | 15.5x | 12.0x | 30.9x |
| Total Debt | $1.02B | $3.59B | $90M | $1.92B | $192M |
| Cash & Equiv. | $38M | $211M | $293M | $511M | $75M |
KOP vs TROX vs IOSP vs AVNT vs BCPC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Koppers Holdings In… (KOP) | 100 | 248.4 | +148.4% |
| Tronox Holdings plc (TROX) | 100 | 126.7 | +26.7% |
| Innospec Inc. (IOSP) | 100 | 99.4 | -0.6% |
| Avient Corporation (AVNT) | 100 | 147.3 | +47.3% |
| Balchem Corporation (BCPC) | 100 | 158.5 | +58.5% |
Price return only. Dividends and distributions are not included.
Quick Verdict: KOP vs TROX vs IOSP vs AVNT vs BCPC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
KOP ranks third and is worth considering specifically for value.
- Lower P/E (9.8x vs 30.9x)
TROX is the #2 pick in this set and the best alternative if dividends and momentum is your priority.
- 3.6% yield, vs AVNT's 2.9%
- +76.9% vs IOSP's -14.9%
IOSP is the clearest fit if your priority is sleep-well-at-night and valuation efficiency.
- Lower volatility, beta 0.70, Low D/E 6.7%, current ratio 2.79x
- PEG 0.48 vs BCPC's 2.41
- Beta 0.70, yield 2.2%, current ratio 2.79x
AVNT is the clearest fit if your priority is income & stability.
- Dividend streak 14 yrs, beta 1.19, yield 2.9%
BCPC carries the broadest edge in this set and is the clearest fit for growth exposure and long-term compounding.
- Rev growth 8.8%, EPS growth 20.9%, 3Y rev CAGR 3.2%
- 160.5% 10Y total return vs IOSP's 84.4%
- 8.8% revenue growth vs KOP's -10.2%
- 15.0% margin vs TROX's -12.3%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 8.8% revenue growth vs KOP's -10.2% | |
| Value | Lower P/E (9.8x vs 30.9x) | |
| Quality / Margins | 15.0% margin vs TROX's -12.3% | |
| Stability / Safety | Beta 0.33 vs TROX's 2.37, lower leverage | |
| Dividends | 3.6% yield, vs AVNT's 2.9% | |
| Momentum (1Y) | +76.9% vs IOSP's -14.9% | |
| Efficiency (ROA) | 9.4% ROA vs TROX's -7.7%, ROIC 12.2% vs -0.3% |
KOP vs TROX vs IOSP vs AVNT vs BCPC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
KOP vs TROX vs IOSP vs AVNT vs BCPC — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
BCPC leads in 2 of 6 categories
KOP leads 1 • TROX leads 0 • IOSP leads 0 • AVNT leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
BCPC leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
AVNT is the larger business by revenue, generating $3.3B annually — 3.1x BCPC's $1.1B. BCPC is the more profitable business, keeping 15.0% of every revenue dollar as net income compared to TROX's -12.3%. On growth, BCPC holds the edge at +8.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $1.9B | $2.9B | $1.8B | $3.3B | $1.1B |
| EBITDAEarnings before interest/tax | $232M | $166M | $198M | $445M | $267M |
| Net IncomeAfter-tax profit | $56M | -$359M | $117M | $158M | $158M |
| Free Cash FlowCash after capex | $68M | -$139M | $88M | $205M | $182M |
| Gross MarginGross profit ÷ Revenue | +17.9% | +5.8% | +27.7% | +31.7% | +36.3% |
| Operating MarginEBIT ÷ Revenue | +8.9% | -4.8% | +8.7% | +9.3% | +21.0% |
| Net MarginNet income ÷ Revenue | +3.0% | -12.3% | +6.6% | +4.8% | +15.0% |
| FCF MarginFCF ÷ Revenue | +3.6% | -4.8% | +4.9% | +6.3% | +17.2% |
| Rev. Growth (YoY)Latest quarter vs prior year | -9.3% | +3.0% | -2.4% | +2.5% | +8.1% |
| EPS Growth (YoY)Latest quarter vs prior year | +3.9% | +7.1% | +167.7% | +3.8% | +10.6% |
Valuation Metrics
KOP leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 15.0x trailing earnings, KOP trades at a 63% valuation discount to AVNT's 41.0x P/E. Adjusting for growth (PEG ratio), IOSP offers better value at 0.51x vs BCPC's 2.62x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $807M | $1.3B | $1.9B | $3.3B | $5.1B |
| Enterprise ValueMkt cap + debt − cash | $1.8B | $4.7B | $1.7B | $4.8B | $5.2B |
| Trailing P/EPrice ÷ TTM EPS | 15.02x | -2.83x | 16.41x | 41.01x | 33.58x |
| Forward P/EPrice ÷ next-FY EPS est. | 9.81x | — | 15.45x | 11.95x | 30.87x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.51x | — | 2.62x |
| EV / EBITDAEnterprise value multiple | 7.42x | 16.80x | 8.29x | 12.22x | 19.83x |
| Price / SalesMarket cap ÷ Revenue | 0.43x | 0.46x | 1.07x | 1.03x | 4.92x |
| Price / BookPrice ÷ Book value/share | 1.46x | 0.92x | 1.44x | 1.40x | 4.14x |
| Price / FCFMarket cap ÷ FCF | 11.96x | — | 21.68x | 17.16x | 29.51x |
Profitability & Efficiency
BCPC leads this category, winning 6 of 9 comparable metrics.
Profitability & Efficiency
BCPC delivers a 12.4% return on equity — every $100 of shareholder capital generates $12 in annual profit, vs $-30 for TROX. IOSP carries lower financial leverage with a 0.07x debt-to-equity ratio, signaling a more conservative balance sheet compared to TROX's 2.48x. On the Piotroski fundamental quality scale (0–9), BCPC scores 9/9 vs TROX's 2/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +9.8% | -30.4% | +9.0% | +6.6% | +12.4% |
| ROA (TTM)Return on assets | +3.0% | -7.7% | +6.5% | +2.6% | +9.4% |
| ROICReturn on invested capital | +8.3% | -0.3% | +11.2% | +3.9% | +12.2% |
| ROCEReturn on capital employed | +10.4% | -0.4% | +11.0% | +4.0% | +14.8% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 2 | 6 | 5 | 9 |
| Debt / EquityFinancial leverage | 1.78x | 2.48x | 0.07x | 0.81x | 0.15x |
| Net DebtTotal debt minus cash | $985M | $3.4B | -$203M | $1.4B | $117M |
| Cash & Equiv.Liquid assets | $38M | $211M | $293M | $511M | $75M |
| Total DebtShort + long-term debt | $1.0B | $3.6B | $90M | $1.9B | $192M |
| Interest CoverageEBIT ÷ Interest expense | 2.36x | -1.16x | — | 3.61x | 15.23x |
Total Returns (Dividends Reinvested)
Evenly matched — KOP and TROX and BCPC each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in BCPC five years ago would be worth $12,424 today (with dividends reinvested), compared to $4,493 for TROX. Over the past 12 months, TROX leads with a +76.9% total return vs IOSP's -14.9%. The 3-year compound annual growth rate (CAGR) favors KOP at 9.1% vs TROX's -8.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +54.7% | +98.1% | +0.5% | +16.0% | +3.6% |
| 1-Year ReturnPast 12 months | +65.7% | +76.9% | -14.9% | +4.1% | -2.2% |
| 3-Year ReturnCumulative with dividends | +29.8% | -23.6% | -17.3% | +2.3% | +26.6% |
| 5-Year ReturnCumulative with dividends | +10.6% | -55.1% | -18.3% | -22.7% | +24.2% |
| 10-Year ReturnCumulative with dividends | +70.5% | +116.1% | +84.4% | +27.8% | +160.5% |
| CAGR (3Y)Annualised 3-year return | +9.1% | -8.6% | -6.1% | +0.8% | +8.2% |
Risk & Volatility
Evenly matched — KOP and BCPC each lead in 1 of 2 comparable metrics.
Risk & Volatility
BCPC is the less volatile stock with a 0.33 beta — it tends to amplify market swings less than TROX's 2.37 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. KOP currently trades 97.1% from its 52-week high vs TROX's 79.4% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 1.12x | 2.37x | 0.70x | 1.19x | 0.33x |
| 52-Week HighHighest price in past year | $42.41 | $10.59 | $95.55 | $44.85 | $183.90 |
| 52-Week LowLowest price in past year | $24.78 | $2.86 | $65.58 | $27.48 | $139.17 |
| % of 52W HighCurrent price vs 52-week peak | +97.1% | +79.4% | +80.2% | +81.4% | +86.7% |
| RSI (14)Momentum oscillator 0–100 | 61.0 | 58.5 | 59.1 | 55.2 | 32.9 |
| Avg Volume (50D)Average daily shares traded | 213K | 3.1M | 221K | 620K | 190K |
Analyst Outlook
Evenly matched — TROX and AVNT each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: KOP as "Buy", TROX as "Buy", IOSP as "Hold", AVNT as "Buy", BCPC as "Buy". Consensus price targets imply 50.1% upside for IOSP (target: $115) vs -13.8% for TROX (target: $7). For income investors, TROX offers the higher dividend yield at 3.60% vs BCPC's 0.54%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $55.00 | $7.25 | $115.00 | $48.40 | $162.00 |
| # AnalystsCovering analysts | 14 | 17 | 9 | 20 | 10 |
| Dividend YieldAnnual dividend ÷ price | +0.8% | +3.6% | +2.2% | +2.9% | +0.5% |
| Dividend StreakConsecutive years of raises | 3 | 0 | 12 | 14 | 11 |
| Dividend / ShareAnnual DPS | $0.31 | $0.30 | $1.70 | $1.08 | $0.87 |
| Buyback YieldShare repurchases ÷ mkt cap | +4.7% | 0.0% | 0.0% | +0.1% | +2.1% |
BCPC leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). KOP leads in 1 (Valuation Metrics). 3 tied.
KOP vs TROX vs IOSP vs AVNT vs BCPC: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is KOP or TROX or IOSP or AVNT or BCPC a better buy right now?
For growth investors, Balchem Corporation (BCPC) is the stronger pick with 8.
8% revenue growth year-over-year, versus -10. 2% for Koppers Holdings Inc. (KOP). Koppers Holdings Inc. (KOP) offers the better valuation at 15. 0x trailing P/E (9. 8x forward), making it the more compelling value choice. Analysts rate Koppers Holdings Inc. (KOP) a "Buy" — based on 14 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — KOP or TROX or IOSP or AVNT or BCPC?
On trailing P/E, Koppers Holdings Inc.
(KOP) is the cheapest at 15. 0x versus Avient Corporation at 41. 0x. On forward P/E, Koppers Holdings Inc. is actually cheaper at 9. 8x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Innospec Inc. wins at 0. 48x versus Balchem Corporation's 2. 41x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — KOP or TROX or IOSP or AVNT or BCPC?
Over the past 5 years, Balchem Corporation (BCPC) delivered a total return of +24.
2%, compared to -55. 1% for Tronox Holdings plc (TROX). Over 10 years, the gap is even starker: BCPC returned +160. 5% versus AVNT's +27. 8%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — KOP or TROX or IOSP or AVNT or BCPC?
By beta (market sensitivity over 5 years), Balchem Corporation (BCPC) is the lower-risk stock at 0.
33β versus Tronox Holdings plc's 2. 37β — meaning TROX is approximately 618% more volatile than BCPC relative to the S&P 500. On balance sheet safety, Innospec Inc. (IOSP) carries a lower debt/equity ratio of 7% versus 2% for Tronox Holdings plc — giving it more financial flexibility in a downturn.
05Which is growing faster — KOP or TROX or IOSP or AVNT or BCPC?
By revenue growth (latest reported year), Balchem Corporation (BCPC) is pulling ahead at 8.
8% versus -10. 2% for Koppers Holdings Inc. (KOP). On earnings-per-share growth, the picture is similar: Innospec Inc. grew EPS 228. 9% year-over-year, compared to -890. 0% for Tronox Holdings plc. Over a 3-year CAGR, BCPC leads at 3. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — KOP or TROX or IOSP or AVNT or BCPC?
Balchem Corporation (BCPC) is the more profitable company, earning 14.
9% net margin versus -16. 2% for Tronox Holdings plc — meaning it keeps 14. 9% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BCPC leads at 21. 1% versus -0. 7% for TROX. At the gross margin level — before operating expenses — BCPC leads at 35. 7%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is KOP or TROX or IOSP or AVNT or BCPC more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Innospec Inc. (IOSP) is the more undervalued stock at a PEG of 0. 48x versus Balchem Corporation's 2. 41x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Koppers Holdings Inc. (KOP) trades at 9. 8x forward P/E versus 30. 9x for Balchem Corporation — 21. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for IOSP: 50. 1% to $115. 00.
08Which pays a better dividend — KOP or TROX or IOSP or AVNT or BCPC?
All stocks in this comparison pay dividends.
Tronox Holdings plc (TROX) offers the highest yield at 3. 6%, versus 0. 5% for Balchem Corporation (BCPC).
09Is KOP or TROX or IOSP or AVNT or BCPC better for a retirement portfolio?
For long-horizon retirement investors, Balchem Corporation (BCPC) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
33), 0. 5% yield, +160. 5% 10Y return). Tronox Holdings plc (TROX) carries a higher beta of 2. 37 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (BCPC: +160. 5%, TROX: +116. 1%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between KOP and TROX and IOSP and AVNT and BCPC?
Both stocks operate in the Basic Materials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: KOP is a small-cap deep-value stock; TROX is a small-cap income-oriented stock; IOSP is a small-cap deep-value stock; AVNT is a small-cap quality compounder stock; BCPC is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.